Microvascular effect of intracoronary eptifibatide in acute myocardial infarction

Cardiology (Switzerland)

Volumn 123, Issue 1, 2012, Pages 46-53

  Iancu, Adrian ^b   Ober, Camelia ^a,b   Bondor, Cosmina Ioana ^b   Cadiş, Horaţiu ^a  

^a Niculae Stancioiu Heart Institute   (Romania)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Acute myocardial infarction; Clopidogrel; Eptifibatide; Microvascular obstruction

Indexed keywords

CLOPIDOGREL; EPTIFIBATIDE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY REPERFUSION; DIASTOLE; DOPPLER ECHOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; INTRACORONARY INFUSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; ST SEGMENT; THROMBUS ASPIRATION; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADOLESCENT; ADULT; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PEPTIDES; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; THROMBOSIS; TICLOPIDINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84866183843     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000341197     Document Type: Article

References (34)

1. Gibson CM, Maehara A, Lansky AJ, et al: Rationale and design of the INFUSE-AMI study: a 2 ! 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction. Am Heart J 2011; 161: 478-486.
2. Thiele H, Schindler K, Friedenberger J, et al: Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Circulation 2008; 118: 49-57.
3. Gurbel PA, Tantry US: Delivery of glycoprotein IIb/IIIa inhibitor therapy for percutaneous coronary intervention: why not take the intracoronary highway? Circulation 2010; 121: 739-741.
4. Davies MJ, Thomas AC, Knapman PA, et al: Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 1986; 73: 418-427.
5. Schwartz RS, Burke AP, Farb A, et al: Microemboli and microvascular obstruction in acute myocardial infarction and sudden coronary death: relation to epicardial plaque histopathology. J Am Coll Cardiol 2009; 54: 2167-2173.
6. Svilaas T, Vlaar PJ, Van der Horst IC, et al: Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008; 358: 557-567.
7. Burzotta F, De Vita M, Gu YL, et al: Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials. Eur Heart J 2009; 30: 2193-2220.
8. Kunichika H, Ben-Yehuda O, Lafitte S, et al: Effects of glycoprotein IIb/IIIa inhibition on microvascular flow after coronary reperfusion: a quantitative myocardial contrast echocardiography study. J Am Coll Cardiol 2004; 43: 276-283.
9. Montalescot G, Barragan P, Wittenberg O, et al: Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001; 344: 1895-1903.
10. Levine GN, Bates ER, Blankenship JC, et al.2011. ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011; 58:e44-e122
11. Mehilli J, Kastrati A, Schulz S, et al: Abciximab in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial. Circulation 2009; 119: 1933-1940.
12. Le May MR, Wells GA, Glover CA, et al: Primary percutaneous coronary angioplasty with and without eptifibatide in ST segment elevation myocardial infarction: a safety and efficacy study of integrilin-facilitated versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction (ASSIST). Circ Cardiovasc Interv 2009; 22: 330-338.
13. Gu YL, Kampinga MA, Wieringa WG, et al: Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial. Circulation 2010; 122: 2709-2717.
14. Bertrand OF, Rodés-Cabau J, Larose MD, et al: Intracoronary compared to intravenous abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial placebo-controlled randomized study. Am J Cardiol 2010; 105: 1520-1527.
15. Thiele H, Wöhrle J, Hambrecht R, et al: AIDA STEMI abciximab intracoronary versus intravenously drug application in ST-elevation myocardial infarction. Lancet 2012; 379: 923-931.
16. Koul S, Smith JG, Scherstén F, et al: Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Eur Heart J 2011; 32: 2989-2997.
17. Pinto DS, Kirtane AJ, Ruocco NA, et al: Administration of intracoronary eptifibatide during ST-elevation myocardial infarction. Am J Cardiol 2005; 96: 1494-1497.
18. Claessen BE, Bax M, Delewi R, et al: The Doppler flow wire in acute myocardial infarction. Heart 2010; 96: 631-635.
19. Iwakura K, Ito H, Kawano S, et al: Assessing myocardial perfusion with the transthoracic Doppler technique in patients with reperfused anterior myocardial infarction: comparison with angiographic, enzymatic and electrocardiographic indices. Eur Heart J 2004; 25: 1526-1533.
20. Okcular I, Sezer M, Aslanger E, et al: The accuracy of deceleration time of diastolic coronary flow measured by transthoracic echocardiography in predicting long-term left ventricular infarct size and function after reperfused myocardial infarction. Eur J Echocardiogr 2010; 30: 1-6.
21. Meimoun P, Tribouilloy C: Non-invasive assessment of coronary flow and coronary flow reserve by transthoracic Doppler echocardiography: a magic tool for the real world. Eur J Echocardiogr 2008; 9: 449-457.
22. Bellandi F, Maioli M, Gallopin M, et al: Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention. Cathet Cardiovasc Interv 2004; 62: 186-192.
23. Goto S, Tamura N, Ishida H: Ability of antiglycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions. J Am Coll Cardiol 2004; 44: 316-323.
24. Speich HE, Earhart AD, Hill SN, et al: Variability of platelet aggregate dispersal with glycoprotein IIb-IIIa antagonists: eptifibatide and abciximab. J Thromb Haemost 2009; 7: 983-991.
25. Neumann FJ, Hochholzer W, Pogatsa-Murray G, et al: Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting. J Am Coll Cardiol 2001; 37: 1323-1328.
26. Berger PB: The glycoprotein IIb/IIIa inhibitor wars: an update. J Am Coll Cardiol 2010; 56: 476-478.
27. Zeymer U, Margenet A, Haude M, et al: Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute STsegment elevation myocardial infarction: results of the EVA-AMI trial. J Am Coll Cardiol 2010; 56: 463-469.
28. Deibele AJ, Kirtane AJ, Pinto DS, et al: Intracoronary bolus administration of eptifibatide during percutaneous coronary stenting for non ST elevation myocardial infarction and unstable angina. J Thromb Thrombolysis 2006; 22: 47-50.
29. Deibele AJ, Jennings LK, Tcheng JE, et al: Intracoronary eptifibatide bolus administration during percutaneous coronary revascularization for acute coronary syndromes with evaluation of platelet glycoprotein IIb/IIIa receptor occupancy and platelet function: the Intracoronary Eptifibatide (ICE) Trial. Circulation 2010; 21: 784-791.
30. Kramer MC, Van der Wal AC, Koch KT, et al: Presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention. Circulation 2008; 118: 1810-1816.
31. Kramer MC, Rittersma SZ, de Winter RJ, et al: Relationship of thrombus healing to underlying plaque morphology in sudden coronary death. J Am Coll Cardiol 2010; 55: 122-132.
32. Wöhrle J, Merkle N, Nusser T, et al: Infarct size after primary angioplasty in patients with bivalirudin compared to unfractionated heparin plus abciximab in STEMI: the HORIZONS-AMI MRI substudy. Am J Cardiol 2009; 104(suppl):68D.
33. Patti G, Bárczi G, Orlic D, et al: Outcome comparison of 600-and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results from the ARMYDA-6 MI (antiplatelet therapy for reduction of myocardial damage during angioplasty-myocardial infarction) randomized study. J Am Coll Cardiol 2011; 58: 1592-1599.
34. Stone GW, Maehara A, Witzenbichler B, et al: Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial. JAMA 2012; 307: 1817-1826.